Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  • SM B
  • Jaeschke R
  • SM S
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Background: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the identification of optimal strategies for the diagnosis of DVT in ambulatory adults.Methods: The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Results: We suggest that clinical assessment of pretest probability of DVT, rather than performing the same tests in all patients, should guide the diagnostic process for a first lower extremity DVT (Grade 2B). In patients with a low pretest probability of first lower extremity DVT, we recommend initial testing with D-dimer or ultrasound (US) of the proximal veins over no diagnostic testing (Grade 1B), venography (Grade 1B), or whole-leg US (Grade 2B). In patients with moderate pretest probability, we recommend initial testing with a highly sensitive D-dimer, proximal compression US, or whole-leg US rather than no testing (Grade 1B) or venography (Grade 1B). In patients with a high pretest probability, we recommend proximal compression or whole-leg US over no testing (Grade 1B) or venography (Grade 1B).Conclusions: Favored strategies for diagnosis of first DVT combine use of pretest probability assessment, D-dimer, and US. There is lower-quality evidence available to guide diagnosis of recurrent DVT, upper extremity DVT, and DVT during pregnancy.

Author-supplied keywords

  • Adult
  • Ambulatory Care
  • Female
  • Fibrin Fibrinogen Degradation Products -- Analysis
  • Fibrinolytic Agents -- Adverse Effects
  • Fibrinolytic Agents -- Therapeutic Use
  • Hemorrhage -- Blood
  • Hemorrhage -- Chemically Induced
  • Hemorrhage -- Prevention and Control
  • Human
  • Magnetic Resonance Angiography -- Methods
  • Male
  • Medical Organizations
  • Medical Practice, Evidence-Based
  • Phlebography -- Methods
  • Predictive Value of Tests
  • Probability
  • Pulmonary Embolism -- Diagnosis
  • Pulmonary Embolism -- Drug Therapy
  • Pulmonary Embolism -- Prevention and Control
  • Risk Factors
  • Thrombosis -- Diagnosis
  • Thrombosis -- Drug Therapy
  • Thrombosis -- Prevention and Control
  • Tomography, X-Ray Computed -- Methods
  • Ultrasonography -- Methods
  • United States
  • Venous Thrombosis -- Diagnosis
  • Venous Thrombosis -- Drug Therapy
  • Venous Thrombosis -- Prevention and Control

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Bates SM

  • R Jaeschke

  • Stevens SM

  • S Goodacre

  • Wells PS

  • Stevenson MD

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free